Ex-Biotech Exec To Admit Lying To SEC, Skip Fraud Retrial
A small-time biotechnology entrepreneur will plead guilty to lying to the U.S. Securities and Exchange Commission and forgo a retrial on fraud charges after a jury deadlocked on whether he misled...To view the full article, register now.
Already a subscriber? Click here to view full article